Appointments at LFB Executive Committee




Les Ulis (France) – 6 April 2023 – LFB announces two appointments today: Philippe Noquéro as Executive Vice President, Operational Excellence and Fabrice Dubois as Executive Vice President, Legal Affairs and Compliance. Both took up their duties on Monday April 3 and are joining the Group’s Executive Committee. Vincent Loret, Executive Vice President, Industrial Affairs, joined LFB and its Executive Committee in November of last year.


For Jacques Brom, Chief Executive Officer of LFB: “The appointments of Vincent Loret as Executive Vice President, Industrial Affairs, Philippe Noquéro as Executive Vice President, Operational Excellence, and Fabrice Dubois as Executive Vice President, Legal Affairs and Compliance, reinforce and renew the Group’s Executive Committee. The solid experience of all three in the pharmaceutical industry, both in France and globally, means they have in-depth knowledge in their respective areas of expertise. These recruitments will support LFB in its future challenges that will be industrial in particular, with the future commissioning of the Arras plant.”


Philippe Noquéro is appointed Head of a new LFB Department 

In close collaboration with the Industrial and Quality departments that were in charge of Operational Excellence until now, Philippe Noquéro will lead the group’s Operational Excellence strategy, support all production sites in this area, and will guarantee the execution of continuous improvement plans, to achieve the group’s performance objectives.

With a doctorate in Pharmaceutical Sciences, and as a Black Belt Master Lean & Six Sigma, Philippe Noquéro has more than 25 years of experience in the pharmaceutical sector, whether in manufacturing, continuous improvement, industrial transfer or the supply chain. During his career, he has served in positions including that of Director of Operational Excellence at Pfizer, J&J and FAMAR (CMO). Since 2013, Philippe Noquéro was European Director of Operational Excellence at Takeda.

The creation of this new department is an initiative spearheaded by Jacques Brom, CEO of LFB since September 2022, with the goal of strengthening the teams and resources allocated to improving procedures and processes. It is part of efforts to support the growing demand for medicinal products produced by LFB used to treat ever more patients with serious and often rare diseases, in France and around the world.


Fabrice Dubois becomes Executive Vice President, Legal Affairs and Compliance

Fabrice Dubois joins LFB as Executive Vice President Legal Affairs and Compliance, and member of the Executive Committee. Fabrice Dubois has spent most of his career in the pharmaceutical sector in international legal functions. He began his career with the Rhône-Poulenc Rorer group and joined Servier in 1999 where he was notably Director of Insurance and Litigation before creating and heading the International Legal Coordination department.

In 2016, Fabrice Dubois supported the setup of the biotech company Intercept Pharmaceuticals in Europe. In his capacity as Regional Legal Director, he participated in the creation of subsidiaries and the implementation of so-called early access programmes before supporting the commercial development of European subsidiaries.

During the past five years, Fabrice Dubois first served as Legal Director of the French, Belgian and Dutch subsidiaries of the US biotech company Biogen, before being appointed in 2021 Global Head of Legal of the business unit Biogen Digital Health, dedicated to personalised and digital medicine in neurosciences.


Vincent Loret has been Executive Vice President, Industrial Affairs at LFB since November 2022

Vincent Loret joined LFB last November as Executive Vice President, Industrial Affairs, and member of the Executive Committee. He is in charge of the operations performed on the group’s four sites located in France as well as all related industrial functions globally, with the goal of ensuring the supply of plasma-derived medicinal products and recombinant proteins for patients.

With a degree in engineering from the French National Institute of Applied Sciences in Toulouse (INSA), before joining LFB, Vincent Loret was in charge of strategy and industrial performance for the Vaccines division of Sanofi since 2019.

After starting his career in the field of vaccines for GSK and Sanofi, Vincent Loret has occupied various positions in production, clinical product development projects and plant construction, in Quality operations. He has also held various positions within the management teams of several sites, in France and abroad, and in particular in Argentina, Hungary, Belgium and Singapore.

Download the Press Release: